a new wave in the medical field: foreign investment helps china's high-quality medical development

2024-09-09

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

pilot areas: biotechnology and wholly-owned hospitals

the notice proposes two pilot directions, namely biotechnology and wholly-owned hospitals. among them, in the free trade pilot zones and free trade ports, foreign-invested enterprises are allowed to engage in the development and application of human stem cells, gene diagnosis and treatment technologies for product registration, listing and production. all products that have been registered, listed and approved for production can be used nationwide. this means that foreign-invested enterprises will participate in the research and development and production of domestic medical technologies and will inject new vitality into china's medical industry.

in addition, the notice also clearly stated that wholly foreign-owned hospitals (except for traditional chinese medicine hospitals and excluding mergers and acquisitions of public hospitals) will be allowed to be established in beijing, tianjin, shanghai, nanjing, suzhou, fuzhou, guangzhou, shenzhen and the entire island of hainan. this means that foreign-owned enterprises will have the opportunity to participate in the construction of china's medical resources and provide more convenient medical services for the people.

pilot mechanism: policy publicity, department coordination and risk management

when implementing the pilot work, each department will play its respective role, increase policy publicity, take the initiative to connect with willing foreign-invested enterprises and strengthen services. at the same time, departments will consult with each other, supervise and manage pilot enterprises in accordance with the law within their respective responsibilities, identify and effectively prevent risks in a timely manner, and solidly promote the pilot work of expanding opening up in the fields of biotechnology and wholly-owned hospitals to ensure that the pilot work achieves practical results.

challenges and opportunities: promoting the transformation and upgrading of the medical industry

these pilot initiatives have brought opportunities to china's medical industry, but they are also facing challenges. perfect laws and regulations, a scientific regulatory system and an effective risk management mechanism are needed to ensure the smooth implementation and effectiveness of the pilots.

overall, this pilot will have a profound impact on the development of china's medical industry. by introducing foreign investment, promoting technological innovation, promoting the integration of medical resources, and building a world-class medical service system, it will bring better and more convenient medical service experience to the chinese people.